Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review.
Bertolini F, Witteveen AB, Young S, Cuijpers P, Ayuso-Mateos JL, Barbui C, Cabello M, Cadorin C, Downes N, Franzoi D, Gasior ME, Gray B, John A, Melchior M, van Ommeren M, Palantza C, Purgato M, Van der Waerden J, Wang S, Sijbrandij M. Bertolini F, et al. BMC Psychiatry. 2023 Mar 20;23(1):181. doi: 10.1186/s12888-023-04641-y. BMC Psychiatry. 2023. PMID: 36941591 Free PMC article. Review.
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.
Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C; STAR Network Investigators. Ostuzzi G, et al. Among authors: bertolini f. PLoS One. 2018 Aug 2;13(8):e0201371. doi: 10.1371/journal.pone.0201371. eCollection 2018. PLoS One. 2018. PMID: 30071042 Free PMC article. Clinical Trial.
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Ostuzzi G, et al. Among authors: bertolini f. BMC Med. 2020 Jul 15;18(1):215. doi: 10.1186/s12916-020-01685-9. BMC Med. 2020. PMID: 32664944 Free PMC article. Review.
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Ostuzzi G, et al. Among authors: bertolini f. BMC Med. 2020 Sep 12;18(1):291. doi: 10.1186/s12916-020-01757-w. BMC Med. 2020. PMID: 32919477 Free PMC article.
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Ostuzzi G, Bertolini F, Del Giovane C, Tedeschi F, Bovo C, Gastaldon C, Nosé M, Ogheri F, Papola D, Purgato M, Turrini G, Correll CU, Barbui C. Ostuzzi G, et al. Among authors: bertolini f. Am J Psychiatry. 2021 May 1;178(5):424-436. doi: 10.1176/appi.ajp.2020.20071120. Epub 2021 Feb 18. Am J Psychiatry. 2021. PMID: 33596679
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study.
Bartoli F, Cavaleri D, Callovini T, Riboldi I, Crocamo C, D'Agostino A, Martinotti G, Bertolini F, Ostuzzi G, Barbui C, Carrà G; STAR Network Depot Investigators. Bartoli F, et al. Among authors: bertolini f. Psychiatry Res. 2022 Mar;309:114405. doi: 10.1016/j.psychres.2022.114405. Epub 2022 Jan 20. Psychiatry Res. 2022. PMID: 35093701
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.
Ostuzzi G, Bertolini F, Tedeschi F, Vita G, Brambilla P, Del Fabro L, Gastaldon C, Papola D, Purgato M, Nosari G, Del Giovane C, Correll CU, Barbui C. Ostuzzi G, et al. Among authors: bertolini f. World Psychiatry. 2022 Jun;21(2):295-307. doi: 10.1002/wps.20972. World Psychiatry. 2022. PMID: 35524620 Free PMC article.
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
Ostuzzi G, Vita G, Bertolini F, Tedeschi F, De Luca B, Gastaldon C, Nosé M, Papola D, Purgato M, Del Giovane C, Correll CU, Barbui C. Ostuzzi G, et al. Among authors: bertolini f. Lancet Psychiatry. 2022 Aug;9(8):614-624. doi: 10.1016/S2215-0366(22)00158-4. Epub 2022 Jun 23. Lancet Psychiatry. 2022. PMID: 35753323
Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study.
D'Agostino A, Aguglia A, Barbui C, Bartoli F, Carrà G, Cavallotti S, Chirico M, Ostinelli EG, Zangani C, Martinotti G, Ostuzzi G; STAR Network Depot Investigators. D'Agostino A, et al. BMC Psychiatry. 2022 Jun 30;22(1):442. doi: 10.1186/s12888-022-04071-2. BMC Psychiatry. 2022. PMID: 35773631 Free PMC article.
531 results